Attached files
| file | filename |
|---|---|
| 8-K - 8-K - OPIANT PHARMACEUTICALS, INC. | v472730_8k.htm |
Exhibit 99.1
| ORIGINALLY ISSUED | PRO-FORMA | |||||||||||||||
| 4/30/2017 | 7/31/2016 | 4/30/2017 | 7/31/2016 | |||||||||||||
| Current assets | ||||||||||||||||
| Cash and cash equivalents | $ | 9,680,454 | $ | 1,481,393 | $ | 9,680,454 | $ | 1,481,393 | ||||||||
| Accounts receivable | - | 312,498 | 3,750,000 | 312,498 | ||||||||||||
| Prepaid expenses | 98,911 | 62,404 | 98,911 | 62,404 | ||||||||||||
| Total currents assets | $ | 9,779,365 | $ | 1,856,295 | $ | 13,529,365 | $ | 1,856,295 | ||||||||
| Other assets | ||||||||||||||||
| Computer equipment (net of accumulated amortization of $3,842 at April 30, 2017 and $1,016 at July 31, 2016) | 3,695 | 6,521 | 3,695 | 6,521 | ||||||||||||
| Patents and patent applications (net of accumulated amortization of $9,417 at April 30, 2017 and $8,388 at Jult 31, 2016) | 18,033 | 19,062 | 18,033 | 19,062 | ||||||||||||
| Total assets | $ | 9,801,093 | $ | 1,881,878 | $ | 13,551,093 | $ | 1,881,878 | ||||||||
| Liabilities | ||||||||||||||||
| Current liabilities | ||||||||||||||||
| Accounts payable | $ | 1,390,780 | $ | 140,584 | $ | 1,718,905 | $ | 140,584 | ||||||||
| Accrued salaries and wages | 1,543,142 | 3,681,250 | 1,543,142 | 3,681,250 | ||||||||||||
| Note payable | - | 165,000 | - | 165,000 | ||||||||||||
| Deferred revenue | 194,800 | 250,000 | 194,800 | 250,000 | ||||||||||||
| Total current liabilities | $ | 3,128,722 | $ | 4,236,834 | $ | 3,456,847 | $ | 4,236,834 | ||||||||
| Deferred revenue | 2,387,084 | 2,350,000 | 2,387,084 | 2,350,000 | ||||||||||||
| Total liabilities | $ | 5,515,806 | $ | 6,586,834 | $ | 5,843,931 | $ | 6,586,834 | ||||||||
| Stockholder's equity (deficit) | ||||||||||||||||
| Common stock; par value $.001; 1,000,000,000 shares authorized; 2,020,380 shares issued and outstanding at April 30, 2017 and $1,992,433 shares issued and outstanding at July 31, 2016 | 2,020 | 1,992 | 2,020 | 1,992 | ||||||||||||
| Additional paid-in capital | 58,549,055 | 56,478,394 | 58,549,055 | 56,478,394 | ||||||||||||
| Accumuated deficit | (54,265,788 | ) | (61,185,342 | ) | (50,843,913 | ) | (61,185,342 | ) | ||||||||
| Total stockholder's equity (deficit) | 4,285,287 | (4,704,956 | ) | 7,707,162 | (4,704,956 | ) | ||||||||||
| Total liabilities and stockholder's equity (deficit) | $ | 9,801,093 | $ | 1,881,878 | $ | 13,551,093 | $ | 1,881,878 | ||||||||